{"slideshow_credits": null, "snippet": "A federal appeals court on Thursday again invalidated a patent protecting Teva Pharmaceutical\u2019s big-selling drug, Copaxone, which can cost $60,000 a year.", "abstract": "Sandoz and Momenta Pharmaceuticals immediately initiate sales of generic drug Glatopa after federal appeals court again invalidates patent for brand-name multiple sclerosis drug Copaxone; decision is serious blow to Teva Pharmaceutical; generic will cost 18 percent less than Copaxone, but will still cost patients more than $63,000 per year.", "section_name": "Business Day", "print_page": "2", "document_type": "article", "byline": {"person": [{"firstname": "Andrew", "role": "reported", "lastname": "POLLACK", "rank": 1, "organization": ""}], "original": "By ANDREW POLLACK"}, "web_url": "http://www.nytimes.com/2015/06/19/business/ruling-may-clear-way-for-generic-version-of-multiple-sclerosis-drug.html", "lead_paragraph": "A federal appeals court on Thursday again invalidated a patent protecting Teva Pharmaceutical\u2019s big-selling drug, Copaxone, which can cost $60,000 a year.", "headline": {"main": "Teva Ruling Clears Way for Generic Version of Multiple Sclerosis Drug", "print_headline": "Teva Loses Patent Case on Lucrative Multiple Sclerosis Drug"}, "_id": "5583120b38f0d85931d0d443", "word_count": "557", "multimedia": [], "pub_date": "2015-06-19T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "1"}, {"name": "subject", "value": "Generic Brands and Products", "is_major": "Y", "rank": "2"}, {"name": "subject", "value": "Multiple Sclerosis", "is_major": "Y", "rank": "3"}, {"name": "organizations", "value": "Teva Pharmaceutical Industries Ltd", "is_major": "Y", "rank": "4"}, {"name": "organizations", "value": "Sandoz International GmbH", "is_major": "Y", "rank": "5"}, {"name": "organizations", "value": "Momenta Pharmaceuticals Inc", "is_major": "Y", "rank": "6"}, {"name": "subject", "value": "Inventions and Patents", "is_major": "N", "rank": "7"}, {"name": "organizations", "value": "Novartis AG", "is_major": "N", "rank": "8"}], "blog": [], "subsection_name": null, "type_of_material": "News"}